Atjaunināt sīkdatņu piekrišanu

E-grāmata: Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future

Edited by
  • Formāts - PDF+DRM
  • Cena: 154,06 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

This book will compile a collection of chapters dedicated to varied aspects of PPPM in neuropsychiatric and neurodegenerative diseases. Among the topics to be covered are:
Recent advances in ALS research
News about Clinical aspects and advanced therapy approaches in personalized treatment of ALS Schizophrenia: New treatments and clinical aspects
Predictive, Preventive and Personalised Medicine in aging macular degeneration
Advances in Multiple Sclerosis Pharmacogenetics, Tailoring Treatment Efficacy, Safety and Regimen Selection
Multiple sclerosis related biomarkers: perspectives for clinical application
Preventive clinical trials in brain aging: new trends & the need of guidelines
MCI_ clinical guidelines in early diagnosis of dementia
Alzheimer's disease: diagnostics, prognostics and the road to prevention
Biomarkers for early diagnosis of Parkinson's and Alzheimer's diseases
Synucleinopathies, tauopathies, TDP-43 proteinopathies and amyloidosis PSP, MSA and other parkinsonisms

Recenzijas

From the reviews:

This book provides an overview of up-to-date literature on existing and potential future predictive, preventive, and personalized therapeutic approaches to neurodegenerative diseases. It is a useful resource for clinicians and researchers interested in the current status of research findings and their potential future applications in this field. (Nilufer Ertekin-Taner, Doodys Book Reviews, October, 2013)

Part I
Time for New Guidelines in Handling of Neurodegenerative Disorders: Optimistic Versus Pessimistic Prognosis by Application of PPPM
3(10)
Silvia Mandel
Olga Golubnitschaja
Part II
Individual Predispositions in Healthy Vasospastic Individuals: Patient Profiling for Targeted Prevention of "Down-Stream" Pathologies as Cost-Effective Personalised Medicine
13(18)
Kristina Yeghiazaryan
Josef Flammer
Olga Golubnitschaja
Idiopathic REM Sleep Behavior Disorder as a Long-Term Predictor of Neurodegenerative Disorders
31(14)
Stephany Fulda
Mauro Manconi
New Animal Models of Progressive Neurodegeneration: Tools for Developing Predictive Diagnostics and Identifying Presymptomatic Therapeutic Targets
45(24)
Amber L. Marriott
Daphne A. Gill
Christopher A. Shaw
R. Andrew Tasker
Tau Pathology: A Selected View on the Current Status
69(26)
Illana Gozes
Part III
The Use of Biomarkers for Prediction and Prevention of Alzheimer's and Parkinson's Diseases
95(46)
Silvia Mandel
Amos D. Korczyn
Clinical Trials of AD Delay of Onset: Enrichment by a Prognostic Genetic Biomarker
141(20)
Iris Grossman
Michael W. Lutz
Donna G. Crenshaw
Ann M. Saunders
Ornit Chiba-Falek
William K. Gottschalk
Allen D. Roses
An Update on CSF Biomarkers of Parkinson's Disease
161(26)
Peter A. LeWitt
Bertrand R. Huber
Jing Zhang
Part IV
Glaucomatous Optic Neuropathy: Risk Assessment and Potential Targets for Effective Prevention and Treatments Tailored to the Patient
187(18)
Olga Golubnitschaja
Kristina Yeghiazaryan
Josef Flammer
Part V
Toward a Personalized Approach in Amyotrophic Lateral Sclerosis: New Developments in Diagnosis, Genetics, Pathogenesis and Therapies
205(30)
Beatrice Nefussy
Vivian E. Drory
Recent Advances in ALS Research: Perspectives for Personalized Clinical Application
235(42)
Chen Benkler
Daniel Offen
Eldad Melamed
Tamar Amit
Silvia Mandel
Moussa B.H. Youdim
Orly Weinreb
Part VI
Exercise in Multiple Sclerosis - An Integral Component of Disease Management
277(24)
Andrea Doring
Caspar F. Pfueller
Friedemann Paul
Jan Dorr
Bridging the Informatics Gap Between Bench and Bedside: Implications to Neurodegenerative Diseases
301(10)
Amnon Shabo (Shvo)
Maurizio Scarpa
Part VII
Personalized Medicine in Rare Pediatric Neurometabolic Diseases
311(18)
Rosella Tomanin
Cinzia Maria Bellettato
Francesca D'Avanzo
Alessandra Zanetti
Adriana Ceci
David Begley
Maurizio Scarpa
Author Index 329(60)
Subject Index 389